rs899474226
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001413043.1(RECQL4):c.-74C>T variant causes a 5 prime UTR premature start codon gain change. The variant allele was found at a frequency of 0.0000207 in 1,593,190 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001413043.1 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RECQL4 | ENST00000617875.6 | c.1394C>T | p.Thr465Met | missense_variant | Exon 8 of 21 | 1 | NM_004260.4 | ENSP00000482313.2 | ||
RECQL4 | ENST00000621189.4 | c.323C>T | p.Thr108Met | missense_variant | Exon 7 of 20 | 1 | ENSP00000483145.1 | |||
RECQL4 | ENST00000532846.2 | c.278C>T | p.Thr93Met | missense_variant | Exon 4 of 9 | 5 | ENSP00000476551.1 | |||
RECQL4 | ENST00000688394.1 | n.417C>T | non_coding_transcript_exon_variant | Exon 2 of 4 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152218Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000231 AC: 5AN: 216364Hom.: 0 AF XY: 0.0000255 AC XY: 3AN XY: 117682
GnomAD4 exome AF: 0.0000201 AC: 29AN: 1440854Hom.: 0 Cov.: 33 AF XY: 0.0000224 AC XY: 16AN XY: 715098
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152336Hom.: 0 Cov.: 34 AF XY: 0.0000269 AC XY: 2AN XY: 74484
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The p.T465M variant (also known as c.1394C>T), located in coding exon 8 of the RECQL4 gene, results from a C to T substitution at nucleotide position 1394. The threonine at codon 465 is replaced by methionine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. -
Baller-Gerold syndrome Uncertain:1
This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 465 of the RECQL4 protein (p.Thr465Met). This variant is present in population databases (no rsID available, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with RECQL4-related conditions. ClinVar contains an entry for this variant (Variation ID: 459322). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt RECQL4 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at